A fully licensed, publicly traded company, biopharmaceutical Danish company producing medical cannabinoids to pharmaceutical distributors targeting the European market

Holds both EU-GMP and EU-GACP in an indoor, leased, 1,200 m2 state-of-the-art production facility utilizing aeroponics-technology and vertical farming located in an industrial area – introducing some of the cleanest world-wide (non-irradiated) flower material to the European market

Currently operational and currently utilizing 400 m2production space and 200 m2 for administration and office space

Currently undertaking, cultivation, propagation trimming, drying, bulk packaging, labelling, finished packaging, imports, exports, wholesale sales, retail sales, storage, and distribution

Current production capacity is ~100 kg year/strain and capable to upscale the capacity to produce ~2,200 kg/year of dried cannabis (based on 1-6 strains)

Expected to deliver its first cannabis and cannabinoids to the market in Q3 2023

At current scale, the company expects to hit €270k/yearly (2 MDKK/yearly) and at full commercial scale, it is expected to generate €6.7 million/yearly (50 MDKK/yearly)

Experienced pharma team with strong competencies within business development, quality assurance and regulatory affairs

Company has offtake agreements are in place expected to generate total revenues of > €10.7 mill (DKK 80 mill) in total for the years 2023-2025

Licence amendments expected Q3 2023 for bulk release / product approval

There is an expansion of 600 m2 possibility to build other production rooms to increase the production capacity to ~2,200 kg/year in the same industrial area – resulting in a highly efficient utilization of square meters

Long term lease (10-years rental agreement)

Facility comes with all supporting fixtures and equipment

Company is seeking a strategic partner to further expand existing facility and operations and capture greater market share or open for full divestiture discussions for the current turnkey project

There is an option to acquire the building within the tenor of the rental agreement (real estate valued at ~€910k)